Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Silent Brain Infarction
NCT03318744Unknown
- Sponsor
- Shenyang First People's Hospital
- Start
- Jan 2018
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in ischemic stroke comparing Aspirin 100mg with Placebo (2 arms). Primary endpoint: composite outcome with any incident stroke, myocardial infarction and all-cause death at 24 months. Status: unknown.
02
Drugs
aspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03318744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318744.